Singapore, Feb. 26 -- The InnoHK Centre for Neuromusculoskeletal Restorative Medicine (CNRM), established by The Chinese University of Hong Kong (CUHK), has signed a Memorandum of Understanding (MoU) with Sweden-based company Cellcolabs AB to establish a strategic international collaboration.

The collaboration is designed to directly support CNRM's upcoming Phase I/II clinical trial investigating mesenchymal stromal cell (MSC) therapy for knee osteoarthritis.

Knee osteoarthritis, a prevalent degenerative condition that erodes joint cartilage and hinders movement, is particularly common in older adults. Standard treatments encompass pain medications, physical therapy, lubricating injections, and surgical procedures. Allogeneic MSC therap...